AMENDMENT NO. 1 TO COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • December 29th, 2005 • Cancervax Corp • Biological products, (no disgnostic substances) • New York
This AMENDMENT NO. 1 TO COLLABORATION AND LICENSE AGREEMENT (this “Amendment”), effective as of January 1, 2005 (the “Amendment Effective Date”), is made by and between CancerVax Corporation, a Delaware corporation having its principal office at 2110 Rutherford Road, Carlsbad, California, 92008, USA (“CancerVax”), and Serono Technologies S.A., a Swiss corporation having its principal office at Zone Industrielle de l’Ouriettaz, 1170 Aubonne, Switzerland (“Serono”). CancerVax and Serono may each be referred to as a “Party” or together, the “Parties”.
